6 Meridian’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,157
Closed -$349K 516
2021
Q2
$349K Buy
8,157
+7
+0.1% +$299 0.03% 214
2021
Q1
$340K Buy
8,150
+1,798
+28% +$75K 0.03% 216
2020
Q4
$296K Buy
6,352
+155
+3% +$7.22K 0.03% 213
2020
Q3
$263K Buy
+6,197
New +$263K 0.03% 210
2018
Q3
Sell
-2,946
Closed -$223K 524
2018
Q2
$223K Buy
+2,946
New +$223K 0.02% 397